BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9871628)

  • 1. Bis-S-acyl-2-thioethyl (SATE)-bearing monophosphate prodrug of beta-L-FD4C as potent anti-HBV agent.
    Li X; Carmichael E; Feng M; King I; Doyle TW; Chen SH
    Bioorg Med Chem Lett; 1998 Jan; 8(1):57-62. PubMed ID: 9871628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
    Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL
    Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 2',3'-dideoxy-L-pyrimidine nucleosides as potential antiviral agents against human immunodeficiency virus (HIV) and hepatitis B virus (HBV).
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    J Med Chem; 1994 Mar; 37(6):798-803. PubMed ID: 8145230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents.
    Chen SH
    Curr Med Chem; 2002 May; 9(9):899-912. PubMed ID: 11966452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-hepatitis B virus activity and metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine.
    Zhu YL; Dutschman DE; Liu SH; Bridges EG; Cheng YC
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1805-10. PubMed ID: 9661025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and comparative evaluation of two antiviral agents: beta-L-Fd4C and beta-D-Fd4C.
    Chen SH; Lin S; King I; Spinka T; Dutschman GE; Gullen EA; Cheng YC; Doyle TW
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3245-50. PubMed ID: 9873711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 2',3'-dideoxy-2',3'-didehydro-beta-L-cytidine (beta-L-d4C) and 2',3'-dideoxy 2',3'-didehydro-beta-L-5-fluorocytidine (beta-L-Fd4C), two exceptionally potent inhibitors of human hepatitis B virus (HBV) and potent inhibitors of human immunodeficiency virus (HIV) in vitro.
    Lin TS; Luo MZ; Liu MC; Zhu YL; Gullen E; Dutschman GE; Cheng YC
    J Med Chem; 1996 Apr; 39(9):1757-9. PubMed ID: 8627596
    [No Abstract]   [Full Text] [Related]  

  • 8. Phosphatidyl-2',3'-dideoxy-3'-thiacytidine: synthesis and antiviral activity in hepatitis B-and HIV-1-infected cells.
    Xie H; Voronkov M; Liotta DC; Korba BA; Schinazi RF; Richman DD; Hostetler KY
    Antiviral Res; 1995 Oct; 28(2):113-20. PubMed ID: 8585765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SATE pronucleotide approaches: an overview.
    Peyrottes S; Egron D; Lefebvre I; Gosselin G; Imbach JL; Périgaud C
    Mini Rev Med Chem; 2004 May; 4(4):395-408. PubMed ID: 15134542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N4-acyl-modified D-2',3'-dideoxy-5-fluorocytidine nucleoside analogues with improved antiviral activity.
    Shi J; Mathew JS; Tharnish PM; Rachakonda S; Pai SB; Adams M; Grier JP; Gallagher K; Zhang H; Wu JT; Shi G; Geleziunas R; Erickson-Viitanen S; Stuyver L; Otto MJ; Watanabe KA; Schinazi RF
    Antivir Chem Chemother; 2003 Mar; 14(2):81-90. PubMed ID: 12856919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and evaluation of novel oxazaphosphorine prodrugs of 9-(2-phosphonomethoxyethyl)adenine (PMEA, adefovir) as potent HBV inhibitors.
    Lu P; Liu J; Wang Y; Chen X; Yang Y; Ji R
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6918-21. PubMed ID: 19889538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virus.
    Le Guerhier F; Pichoud C; Jamard C; Guerret S; Chevallier M; Peyrol S; Hantz O; King I; Trépo C; Cheng YC; Zoulim F
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1065-77. PubMed ID: 11257017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of 2',3'-dideoxy-beta-L-5-fluorocytidine (beta-L-FddC) and 2',3'-dideoxy-beta-L-cytidine (beta-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro.
    Lin TS; Luo MZ; Liu MC; Pai SB; Dutschman GE; Cheng YC
    Biochem Pharmacol; 1994 Jan; 47(2):171-4. PubMed ID: 8304960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Placidi L; Faraj A; Loi AG; Pierra C; Egron D; Cretton-Scott E; Gosseli G; Périgaud C; Martin LT; Schinazi RF; Imbach JL; el Kouni MH; Bryant ML; Sommadossi JP
    Antivir Chem Chemother; 2001 Mar; 12(2):99-108. PubMed ID: 11527047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-HIV and anti-HBV activity and resistance profile of 2',3'-dideoxy-3'-thiacytidine (3TC) and its arylphosphoramidate derivative CF 1109.
    Balzarini J; Wedgwood O; Kruining J; Pelemans H; Heijtink R; De Clercq E; McGuigan C
    Biochem Biophys Res Commun; 1996 Aug; 225(2):363-9. PubMed ID: 8753770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of hepatitis B virus inhibition by novel 2'-fluoro-2',3'-unsaturated beta-D- and L-nucleosides.
    Pai SB; Pai RB; Xie MY; Beker T; Shi J; Tharnish PM; Chu CK; Schinazi RF
    Antivir Chem Chemother; 2005; 16(3):183-92. PubMed ID: 16004081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides.
    Van Draanen NA; Tisdale M; Parry NR; Jansen R; Dornsife RE; Tuttle JV; Averett DR; Koszalka GW
    Antimicrob Agents Chemother; 1994 Apr; 38(4):868-71. PubMed ID: 7518218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amidate Prodrugs of Deoxythreosyl Nucleoside Phosphonates as Dual Inhibitors of HIV and HBV Replication.
    Liu C; Dumbre SG; Pannecouque C; Huang C; Ptak RG; Murray MG; De Jonghe S; Herdewijn P
    J Med Chem; 2016 Oct; 59(20):9513-9531. PubMed ID: 27748590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
    Fu XZ; Jiang SH; Yang YS; Ji RY
    Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Some new acyclic nucleotide analogues as antiviral prodrugs: synthesis and bioactivities in vitro.
    Tang YB; Peng ZG; Liu ZY; Li YP; Jiang JD; Li ZR
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6350-3. PubMed ID: 17888662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.